Psoriasis is a chronic, immune-mediated inflammatory disease characterized by dysregulated IL-23/IL-17 axis signaling and keratinocyte hyperproliferation, resulting in well-demarcated erythematous plaques with silvery scale. Beyond cutaneous involvement, psoriasis has been linked to systemic inflammation contributing to increased risk of cardiometabolic and other inflammatory comorbidities.
Download our free Psoriatic Arthritis Questionnaire
Download our free biologics Quick Reference Chart for dermatology
Download our free JAK/TYK2 Inhibitors for Dermatology Quick Reference Charts
Download our free Quick Reference Chart for Topical Non-steroidal and Fixed Combination Therapies
Download our free Quick Reference Chart for Vaccines and Systemic Therapies Chart
Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science
Case author Danna Calder, MMSc, PA-C presents a case of a 34-year-old male with severe, recalcitrant psoriasis achieving remarkable improvement after decades of treatment challenges.
69.5 percent of patients demonstrated improvement or remission of psoriasis after metabolic bariatric surgery for obesity
Elana Gotkine (HealthDay News)
